Seeking Alpha4d
Corcept Therapeutics: The ROSELLA Trial Presents A Major Win For The Company
Corcept Therapeutics' stock surged over 80% after its Phase 3 ROSELLA trial met its primary goal, showing promise for relacorilant in treating platinum-resistant ovarian cancer. The ROSELLA trial ...
Morningstar5d
Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
In ROSELLA, patients treated with relacorilant in addition to nab-paclitaxel chemotherapy experienced a 30 percent reduction in risk of disease progression compared to patients treated with nab ...
The Register-Guard18d
Rosella (Rosie) Andreason
Rosella (Rosie) was welcomed into Heaven early on Sunday morning, March 16, 2025. She passed away peacefully in the comfort of her home with her husband and children by her side. She was 89 years ...
The Highlands Current6d
Wag of the Week: Rosella
This week we met Rosella, a 6-month-old puppy that ARF says is sweet and playful but requires an adult family to train her. She loves other dogs, people, hiking, going on long walks and spending time ...
BioSpace6d
Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
In ROSELLA, patients treated with relacorilant in addition to nab-paclitaxel chemotherapy experienced a 30 percent reduction in risk of disease progression compared to patients treated with ...